Documentation guide
How to Review a WOLVERINE Blend COA: Product, Lot, Method, and Result

A WOLVERINE Blend COA should identify the multi-analyte material under review. Begin with the product name, total labeled strength, and named BPC-157 and TB-500 components. A report that identifies only one standalone component cannot be treated as an exact blend record.
Match the lot or sample identifier next. This is the field that makes documentation specific to the material being evaluated. A result associated with another lot, strength, or blend is not a substitute, even where the product family or component names look similar.
Then note the issuing laboratory and analysis date. Those fields establish the stated scope and timing of the report. They do not make a result transferable, but they allow a reviewer to understand which named sample was analyzed and when.
Read the method before relying on the result. HPLC can describe relative purity, while molecular identity, measured content, and endotoxin status require separate stated methods. A complete review keeps those analytical questions separate instead of treating one result as proof of every product attribute.
For a dual-analyte blend, component-level context is essential. Where the record reports BPC-157 and TB-500 results separately, evaluate each against its stated method and the identified sample. Do not extend a finding from one component into a conclusion about another product or lot.
A COA documents the identified sample, methods, analysis date, and reported result. It does not supply medical, veterinary, dosing, administration, or outcome information. WOLVERINE is supplied by EVLV strictly for lawful laboratory and analytical research.


